Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
3
self-reported 2–10 band
Founded
2021
5 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Uray is a game-changing urinalysis platform that uses photonics and AI technologies to replace dry chemistry & flow cytometry providing comprehensive urine test results within 10 seconds with laboratory accuracy.
Our solution helps people to prevent chronic kidney disease (CKD), urolithiasis disease, urinary tract infection (UTI), abnormal pregnancy and many more.
Uray is able to track 20 biomarkers with laboratory accuracy detecting multiple health conditions from a single urine sample.
Uray system consists of device and mobile application which are synchronized via Wi-Fi allowing to receive and collect test results remotely.
===== Uray solution at-a-Glance:
Show all 9 entries
- handheld device for urinalysis PoCT & home-based
- no more than 10 seconds for the test
- laboratory accuracy with photonics & AI technologies
- comprehensive diagnostics according to 20 biomarkers
- smartphone is not required due to an IoT solution
- completely non-invasive and reagent-free
- disposable urine containers are utilized
- no contact with body fluids, easy to clean
- longitudinal monitoring of health dynamics
===== About:
Uray is a MedTech Startup with a team of experts in photonics, machine learning, hardware development, medical devices marketing and sales.
We have completed the proof of concept stage and almost finished the MVP, assembled a small batch of devices for testing in clinics.
===== We are looking for:
- Cooperation
with nephrology communities, practicing nephrologists, experts, medical centers to validate our technology and perform clinical trials
- Investment
to go from prototype to series production, to perform medical registration, to start pilot sales in Singapore
Specialties
- artificial intelligence
- ai
- healthcare
- iot
- screening
- medical devices
- medtech
- digital healthcare
- internet of things
- nephrology
- machine learning
All 20 specialties
- Medical Devices
- Urinalysis
- Digital Healthcare
- Urine Analysis
- MedTech
- Artificial Intelligence
- AI
- Point of Care Testing
- PoCT
- Preventive Medicine
- Machine Learning
- Internet of Things
- IoT
- Healthcare
- Screening
- Chronic Kidney Disease
- CKD
- UTI
- Photonics
- Nephrology
Related specialties
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SGSingaporePrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Uray - IoT urinalysis solution?
The record holds 3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Uray - IoT urinalysis solution have offices?
One address on record, Singapore only. Primary: Singapore.
Has Uray - IoT urinalysis solution raised funding?
None linked to this brand.
What does Uray - IoT urinalysis solution list as its specialties?
20 tags on the brand's own list, among them artificial intelligence, ai and healthcare.
Which companies are listed alongside Uray - IoT urinalysis solution?
8 profiles list Uray - IoT urinalysis solution as a peer — 84th percentile in Medical Equipment Manufacturing. It lists ten peers of its own. RNAscence Biotechnology and Theia Health list it back.